N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-2,3-dimethylphenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

ID: ALA4551490

PubChem CID: 138393291

Product Number: R613202, Order Now?

Max Phase: Preclinical

Molecular Formula: C29H25FN4O4

Molecular Weight: 512.54

Molecule Type: Unknown

Associated Items:

This product is currently unavailable

Names and Identifiers

Canonical SMILES:  Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C

Standard InChI:  InChI=1S/C29H25FN4O4/c1-17-18(2)25(38-22-13-14-31-26(16-22)33-27(35)19-5-6-19)12-11-24(17)32-28(36)23-4-3-15-34(29(23)37)21-9-7-20(30)8-10-21/h3-4,7-16,19H,5-6H2,1-2H3,(H,32,36)(H,31,33,35)

Standard InChI Key:  PETCZXAONWLUFT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   11.2464  -10.5416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9544  -10.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6586  -10.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6586  -11.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9569  -11.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2464  -11.3657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5342  -11.7734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5342  -12.5928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2463  -13.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2452  -13.8168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5327  -14.2287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8285  -13.8218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8259  -13.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1205  -14.2336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4083  -13.8218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7002  -14.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8827  -14.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2914  -14.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4083  -13.0023    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3708  -10.1334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3708   -9.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0788   -8.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0788   -8.0868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7869   -7.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4949   -8.0868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4950   -8.9063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7869   -9.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7869  -10.1334    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2072   -9.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9155   -8.9065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6199   -9.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6199  -10.1332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9180  -10.5399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2072  -10.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3321  -10.5408    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6586   -8.9062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9544   -9.3149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5381  -10.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 17 16  1  0
 17 18  1  0
 16 18  1  0
 15 19  2  0
  3 20  1  0
 20 21  1  0
 21 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  1  0
 22 27  1  0
 27 28  2  0
 29 26  1  0
 30 29  2  0
 31 30  1  0
 32 31  2  0
 33 32  1  0
 34 33  2  0
 29 34  1  0
 32 35  1  0
 21 36  2  0
  2 37  1  0
  1 38  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

RIPK3 Tchem Receptor-interacting serine/threonine-protein kinase 3 (468 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RIPK2 Tchem Serine/threonine-protein kinase RIPK2 (1546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RIPK1 Tchem Receptor-interacting serine/threonine-protein kinase 1 (1548 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (163371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.54Molecular Weight (Monoisotopic): 512.1860AlogP: 5.38#Rotatable Bonds: 7
Polar Surface Area: 102.32Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.90CX Basic pKa: 4.91CX LogP: 4.98CX LogD: 4.98
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.35Np Likeness Score: -1.64

References

1. Hart AC, Abell L, Guo J, Mertzman ME, Padmanabha R, Macor JE, Chaudhry C, Lu H, O'Malley K, Shaw PJ, Weigelt C, Pokross M, Kish K, Kim KS, Cornelius L, Douglas AE, Calambur D, Zhang P, Carpenter B, Pitts WJ..  (2020)  Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage.,  11  (3): [PMID:32184955] [10.1021/acsmedchemlett.9b00065]
2. EUbOPEN.  (2023)  EUbOPEN Chemogenomics Library - IncuCyte,  [10.6019/CHEMBL5303304]